Afternoon, welcome to our Q4 2021 earnings call. My name is Jodi Allen, and I'm joined virtually by our CEO, Ilham Kadri, our CFO, Karim Hajjar, and today we are also joined by Philippe Kehren, President of Solvay's Soda Ash and Derivatives Business. Today's call is being recorded and will be made available for replay on the investor relations section of our website shortly after the webcast has concluded. I would like to remind all participants that the presentation includes forward-looking statements which are subject to risks and uncertainties. You may refer to the slides related to today's broadcast, which are available on our website. With that, I'll turn the call over to Ilham.
Jodi, hello, everyone. I'll begin my remarks as usual with the health and safety overview shown on slide three. As of last week, we have 158 colleagues who are infected with COVID-19. The number of confirmed cases is down significantly from a peak of 430 on January 28th.
Hello, operator.
Hello. I think we have a technical issue. We have no more sound.
Okay. Can you ask everyone to bear with us, please, for a few minutes while we resolve the issue?
Yeah. Everyone is hearing you. Ladies and gentlemen, please wait a few minutes. The conference will begin again.
The impact of the Omicron variant was particularly apparent in the Solvay workforce in the United States of America, Italy, and France over Q4 and into the new year. Although the number of cases continues to drop across the company, we must remain vigilant as we gradually and carefully look to reopen our administrative sites with measures in place to protect our employees and their communities. We will continue to work in a hybrid mode as pandemic control measures ease. On top of that, we will continue to use the Solvay Solidarity Fund and have used over EUR 6.4 million out of the EUR 15 million collected from investors, management team, and directors' donations to support our people and communities in 13 countries around the world. This leads me to our sustainability program, Solvay One Planet, which is an integral part of our strategy.
I would like to celebrate some of our achievements in 2021, which are shown on slide four. As you know, Solvay is fully committed to reducing carbon emissions. Here you see that we continue to make excellent progress against our targets. The impact of the pandemic on 2020 activity levels is well-known, so the increase in emissions in 2021 comes as no surprise. What is most significant is the fact that we have achieved an 11% reduction across the three-year period, which means we are surpassing our targets to be aligned with the Paris Agreement 6.6% cumulatively very substantially. Last quarter, we announced our ambition to reach carbon neutrality before 2040 in all businesses and before 2015 Soda Ash.
We are accelerating our efforts in this area by announcing today another major project to transition to cleaner energy in our largest soda ash plant in Devnya, Bulgaria, and Philippe will give you more details shortly. Our climate efforts are getting recognized, and we were recently recognized by the rating agency, the Carbon Disclosure Project or CDP, which upgraded Solvay from B to A minus, and we are proud to be in this leadership band and higher than the chemical sector average of B. Slide five shows a summary of our rating from various independent rating agencies. We have made many more achievements in our other two pillars, Resources and Better Life, which we have highlighted in our Q4 earnings press release.
As an example, in Q4, we announced the launch of our very first employee stock ownership plan, offering the employees the opportunity to buy shares at a 10% discount. We are very proud of the strong progress as we deliver on our ambitious roadmap. There is much more to do and this remains a key priority for Solvay and is directly aligned with our company purpose and our strategy. Moving now to our full results shown on slide six. 2021 marks another great year of progress in our transformation journey. We are emerging stronger on all fronts, from pricing power to profitability, from cash generation to returns. I'm proud of the strong performance we delivered in the Q4 as we navigated new challenges facing the chemical industry and overcame these headwinds with necessary price actions to maintain and actually increase our margins.
Our businesses continue to do an outstanding job managing an environment of inflationary pressures, supply chain constraints and lingering uncertainty due to what we hope are the last stages of the pandemic. Let me here extend a sincere thank you to our teams globally for their continued hard work and unrelenting focus on serving our customers. Without you, we would not be in the strong position we are in coming out of the pandemic in 2020 and a year beset with challenges in 2021. Comparing the Q4 of 2021 to the previous year quarter, sales were up 22% on an organic basis. Up 17% versus the full year 2020. Of these 17%, 12% growth was from volumes and 5% from pricing.
We accelerated our pricing efforts in the Q3 and began to realize the benefit in Q4, achieving 12% growth from price increases. This is the highest single-quarter level of price achievements in the past five years. Sales for the full year were up over 4% versus 2019 pre-crisis levels, and this is without the full recovery, as you know, of the civil aero markets. Demand in all our key end markets was strong in Q4, with double-digit growth driven by automotive, agro & feed, electronic, and consumer markets. Likewise, our full year 2021 sales performance exceeded market growth in this same core area. Geographically, all regions delivered double-digit organic sales growth versus Q4 2020. Europe was up by 14%. Asia Pacific, China up by 19%, and the rest of Asia up more than 30%.
North America was up 22% and Latin America was up by 33%. The double-digit top-line growth and EUR 40 million of structural cost reduction resulted in strong EBITDA performance in the Q4, up 24% organically. For full year 2021, Solvay reported a record EBITDA of EUR 2.35 billion. Up 27% organically versus 2020, despite the higher inflationary environment and unfavorable energy headwinds. We also surpassed 2019 EBITDA levels by 8%, twice the top line growth, demonstrating strong operating leverage. This is the result of volume growth, our accelerated pricing initiative and ongoing restructuring and cost takeout measures. We're also marking the achievements of a new milestone, namely delivering returns of 11.4% in 2021.
Remember, back in 2019, when we first launched our growth strategy, the return on capital employed was 8.1%, and we committed to exceed 11% by 2024. The strength of our operational performance, combined with the optimization and rationalization of our assets and pruning of some product lines, enabled us to deliver on these targets three years ahead of plan. Last but not least, we continue to deliver strong cash performance. As you are likely aware, we laid the foundation back in 2019 when we put in place a new incentive structure and more focused and disciplined governance. You saw us accelerate our delivery during the pandemic, and we have continued to deliver. This is in fact the 11th consecutive quarter of positive free cash flow generation. Why is this important?
Because our strong cash generation enables us to invest for the future, and we have a number of exciting growth opportunities thanks to our customers who value our sustainability driven innovations and come to us with even more opportunities. Speaking now about investments, as you have witnessed following our batteries webinar a few weeks ago, we are switching gears from getting fit to changing the game through the acceleration of our investments. In batteries we are investing EUR 300 million in the next two years in Tavaux, France. I encourage you to listen to the webcast replay available on our website to learn more about our ambitions and targets in the auto and batteries markets. In addition, just this week, we announced new investments that affirm our number one leading position in the U.S. sulfone polymers markets.
We are increasing the capacity of polymers such as PSU, PESU, and PPSU, which serve growth in various markets including healthcare, water purification, and food industries. Finally, similar to the auto webinar, I plan to host other dedicated webinars throughout this year, either a standalone event or a spotlight topic during our earnings calls. The objective of this webinar is to introduce some of our global business unit presidents and other experts and leaders in order to share more about their business strategies and performance highlights and to help address the many good questions you have. Today I'm very pleased to be joined here physically, actually in Brussels, by the President of our Soda Ash and Derivatives Business, Philippe Kehren.
Philippe has been with the company for 26 years and has accumulated a wide range of experiences from finance, managing energy and clean energy production, to leading transformation projects and customer relations in the Europe, Middle East and Africa region. In the fall of 2020, he accepted to become the President of the Soda Ash and Derivatives business, where he and his team have been driving the business transformation flawlessly on both the operations and sustainability fronts. Philippe will now give you an overview of the soda ash business and current market environment. Happy to have you here, Philippe. Now I'll turn the floor to you.
Thank you very much, Ilham. Hello everyone. Very happy to be here as well. Well, since taking this role, the objectives of this business have been crystal clear to me. To focus on cost competitiveness and sustainability and to continue to drive cash generation. We have also leveraged the transformation done at group level to build a leaner and fit for purpose organization for our business. Now, today, I would like to share with you an overview of our markets. I'll discuss the pricing environment and contract status for 2022. We will also take a look at our world-class assets and leading cost position, and I'll update you on the step changes we are making with our energy transition projects. What is Soda Ash and Derivatives at Solvay? Our business has annual sales of EUR 1.5 billion.
We operate in 11 production sites globally. nine are producing Soda Ash and bicarbonate, and two are producing raw materials. We have 3,200 employees. We serve customers everywhere in the world. Now let's start with our markets. Soda Ash and sodium bicarbonate are considered as essential chemicals that serve resilient and growing end markets. There is a large number of diversified markets for these chemicals. By far, the largest market is still for glass manufacturing. About 50% of our Soda Ash sales today are used in glass for building, automotive, food and beverage containers, and also for new growing applications such as photovoltaic panels. About 25% of our Soda Ash is used as a water softener for detergents. It's also used in various industrial applications and also in new applications that are developing, such as lithium carbonate for batteries.
Of course, we also use Soda Ash to produce sodium bicarbonate ourselves, which we have branded as Bicar. Bicar represents 25% of our sales, mainly serving four markets, flue gas treatment with our Solvay solution and also feed, food and pharma. These markets are backed by sustainable mega trends, including resource efficiency. For example, the need for double-glazed windows to improve energy efficiency. Other drivers like recyclable packaging, for example, its use in glass containers supports the reduction in use of single-use packaging. Another trend is emission control, where, for example, our Solvay branded sodium bicarbonate is used in flue gas treatment to clean air. We have even developed very recently a solution for ships to depollute their exhaust gas. Most of our markets have been resilient through the COVID-19 pandemic, and in fact, today's demand is back at pre-COVID sales levels.
Our markets are expected to grow by 2% per year for Soda Ash and 4% per year for sodium bicarbonate. Now let's move to our business environment, pricing and contracts. On slide 10, on the left chart, you have a good overview of the evolution of market demand and pricing dynamics of this business over the past five years. The chart on the right shows the evolution of our profits through the same time period using normalized data. What you can clearly see is the demand reduction in 2020. As volumes recovered in 2021, the margin squeeze that occurred during 2021 as a result of the significant cost inflation impacting the business, first on sea freight and then starting in the summer of 2021 on the energy markets in particular in Western Europe.
Despite the margin squeeze that had a significant impact on our EBITDA, we have been able to deliver a strong cash performance thanks to a strict discipline on fixed costs, thanks to very tight asset management and also thanks to a very strong working capital management. For the first time in our history, we've been able to renegotiate conditions on fixed price contracts. I take this opportunity to thank our customers who supported us during these unprecedented times. We have not been able to fully offset all the extra costs, but this allowed us to continue to safely supply them and to move forward with our energy transition investments. As most of you are well aware, the majority of our contracts are negotiated annually, and we've just completed our 2022 negotiations.
I'm pleased to report that our negotiations for 2022 have been successful, better than the market average. For your reference, the latest public data published by analysts such as IHS indicates an average pricing that increased by 27% in Europe and by more than 50% on the export markets, and then that some surcharge clauses have been introduced to face this unprecedented cost situation on logistics and energy. Given the surge in energy costs in late 2021, it was critical for Solvay to increase pricing in order to manage the strong cost inflation, of course, but beyond that, to recover pre-COVID profitability levels. This is absolutely needed to support the investments that are required to execute our energy transition and to be able to invest in capacities that are needed by our customers. Now let's move to our assets and our cost position.
Solvay is a global leader in Soda Ash, operating world-class assets. On the chart of slide 11, you can see the cost merit curve of the industry on a FOB basis, meaning the cash cost to bring the product to the nearest harbor. Our synthetic and natural Soda Ash sites are highly competitive, with 75% of our capacity in the first quartile of the industry cost curve, which you can see here on the chart. These world-class sites are able to serve any customer anywhere in the world. The remainder of our assets, so-called regional assets, are the most competitive in their regional markets. They are not designed to export, so the FOB cost to the nearest port is not relevant for them, but they offer local, competitive and secure supply to our customers there.
They are better positioned than the world-class assets, as you can see in the top right corner. This competitive position takes a continuous and focused effort by our entire business and all the teams. We've been relentless in finding ways to reduce process costs. In fact, we have reduced costs by EUR 50 million in the last two years since I took the role, and we have reduced costs by about EUR 200 million in the past 10 years. This is how we maintain our leadership position. We have six synthetic plants in Europe that are sustainable and competitive in the long run, along with our natural soda ash unit in the U.S. This gives us a unique portfolio of assets in the market.
Even though new developments will likely take place in the natural production of Soda Ash, synthetic production remains a critical source across the long term, given that there are not enough natural trona resources on the planet. On Bicar, we continue to consolidate our leadership position. We are producing Bicar at all of our Soda Ash plants, and we have two additional units only dedicated to Bicar in the U.S. and in Thailand. As a reminder, back in 2019, we announced an investment in our site in Bulgaria to build a new bicarbonate plant to meet the growing demand. I'm happy to share that we have completed this expansion and the new capacity is now available. That is 15% additional capacity available for our customers. Finally, in order to make all our plants sustainable, it is absolutely key to do their energy transition.
We made significant progress in 2021 and very recently, and that will be the last part of my talk today. As part of Solvay One Planet sustainability roadmap, the Soda Ash business has committed to become carbon neutral before 2050, and to phase out coal by 2030. We have already taken a number of steps in our European and U.S. plants to enable such a transition away from coal usage. In 2021, our site in Rheinberg in Germany began the process of switching from coal to using biomass derived from waste wood chips. The first boiler has been operating since May 2021, and we approved the construction of the second one. Rheinberg is set to become the world's first soda ash plant powered primarily by renewable energy by 2025.
Last week, we have officially announced that our site in Dombasle in France will exit coal completely and transition to 100% primarily refuse-derived fuel as early as 2024 to cut emissions by half. This is the first project of its kind in France. Those two projects will use local resources and develop a circular economy. Plans are also underway to transition our Green River, Wyoming plant from coal to gas in two stages to be completed by 2023. Today, we also announced the first step in our largest European site in Devnya, Bulgaria, by converting a boiler to biomass. The biomass will come from a variety of sources, including locally sourced sunflower husk pellets. This boiler is projected to come on stream in November of this year. Today, as we speak, we have already cut our emissions by 5% versus 2018.
By 2025, with the projects I just described, we will have achieved 20% emission reduction in our global business. By 2030, we target a 30% reduction with more projects. As a reminder, each of these projects are economically profitable, and they further de-risk our operations, in particular, by removing the exposure to the highly volatile fossil fuel markets. Beyond this, we plan to initiate new process innovations and other energy technologies to support the exit of coal in our hard to abate sites. The transformation is not only part of our sustainability ambition, but it is valuable to all stakeholders, our customers, our employees, and our investors. That's to keep our sights at the forefront of the industry in terms of reduced environmental impact and cost competitiveness. Thank you very much. Now back to you, Ilham.
Thank you very much, Philippe. Really happy to have you with us today. I just want to say great job to you and to your global team, who I know are listening to you today for not only the successful completion of your contracts, and I know you've done something historical by reopening them in Q4, but the exemplary way you are driving our cultural environment and an operation transformation. Now, ladies and gentlemen, I would like to pass the floor to Karim, who will, as traditionally, review in more details the group segments and financial performance in the Q4 of 2021. Karim?
Thank you, Ilham. Good morning. Good afternoon, everybody. I'll start with an overview of the three business segments, and as usual, we'll refer to figures on an organic basis, by which I mean at constant scope and currency. Beginning with Materials on slide 13. Sales in the segment increased 20.2% in Q4 as Specialty Polymers delivered yet another record quarter. Growth was once again driven by automotive, EV batteries, and electronic markets, each with double-digit sales growth. The growth in auto, by which I include batteries, grew by 31% over the full year 2021. We expect continued strong growth over the next decade and beyond, as we shared with you in our recent auto batteries webcast earlier in the month. That's not the only driver. Our polymers are adding real value in a number of key markets.
Polymers sold in the electronic sector grew 19%, boosted by semiconductors, electrical components, and of course, smart devices. Sales grew by 11% in healthcare, which includes polymers used in medical devices and in pharmaceutical packaging. Our technologies are adding unique, significant differentiated value. As a result, we continue to win new business. Specialty Polymers is exiting the three-year cycle, 2019-2021, as a clear winner against our most formidable peers in high performance polymers, be it PEEK, PTFE, PPA, to name but a few. Turning to Composites. We saw sales recover strongly from what was at a low point of the pandemic in Q4 2020, with organic sales up 24%. Growth was driven by the increase in single aisle aircraft production, for example, the Boeing 737 MAX, the A320neo, the A220 aircraft as well.
These grew 57% from the 2020 low points. Sales to the space and the defense markets grew by 2% in Q4 as launch and other defense programs partially offset the temporary reduction in the F-35 program build rates. For the full year, our civil aero business was down 11% versus 2020, and our space and defense sector grew by 8%. Solvay's diversified presence across multiple aero and defense platforms allows us to have less exposure to the softness, to the weakness in twin aisle wide-body aircraft production rates. That's important. It's also important to recognize and to note that the supply chain and the delivery constraints that we've experienced are continuing. This market creates challenges, be it in raw materials, logistics, and also in labor availability.
Turning to profitability, the EBITDA, the Materials segment increased 31.4% year-on-year, and our EBITDA margins improved almost 300 basis points to 27.5%, primarily due to record sales in Specialty Polymers and of course, the benefits of price increases that have helped to offset inflationary cost pressures in both of our businesses. Now I'm gonna turn to slide 14 to review the Solutions segment, which, as you can see, delivered sales growth of 28% in the Q4. Beginning with Novecare, sales were up 33% almost thanks to both volumes and pricing driven by core markets including agriculture, coatings, home and personal care, each of those delivering double-digit growth. Oil and gas, which is now reported separately as of the Q3 , was up by 88% in the Q4, driven by strong pricing predominantly.
The Aroma Performance business achieved record results in the Q4, with sales growth approaching 37%, thanks to good demand across all product lines. In Special Chem, Q4 sales grew modestly by nearly 2% driven by electronics, which partially offset lower sales to auto. Technology Solutions had another good quarter with sales growth of 15.4% driven by mining and by phosphorus derivatives. As I wrap up Solutions, the segment delivered 29% EBITDA organic growth compared to Q4 2020, and that reflects a strong and continued recovery together with our pricing across most markets, while EBITDA margin rose modestly to 17%. Turning to Chemicals on slide 15.
You've heard Philippe, but if you look at the whole segment, Q4 sales in the segment were up 18%, with all businesses, all of them, experiencing organic growth year-on-year. Philippe has already covered Soda Ash business, so I won't go into that any further. Of course, we can take your questions. Peroxide sales were up organically 16.5% in Q4, driven by volumes and by price, as market conditions remained strong in hydrogen peroxide for the merchant market as well as for the HPPO mega plants. The silica business also performed well with a 13% sales growth in the quarter, thanks to pricing initiatives. Now, although tire demand is still slightly down compared to 2019 levels, demand remains strong for the specialty grades that the silica business specializes in, and that's important.
An example of this is a recent innovation, by the way, called Texyn, which you may recall is a result of a collaboration with some key partners, including Bridgestone. The Coatis business in Latin America continued its exceptional growth momentum, with Q4 sales up 59%, thanks to sustained demand in key markets and increased pricing power. The Chemical segment had very strong performance in the Q4. Well, nearly a 37% growth in EBITDA, thanks to sales, volume growth, and strong pricing management in each and every one of our businesses, supported again by exceptional performance in Coatis and indeed in RusVinyl.
I'll now move to the group's financials on slide number 16. First, the significant inflationary cost headwinds that we flagged in Q2, you recall we mentioned EUR 200 million-EUR 250 million that we updated to around EUR 400 million at beginning of November last year. Well, the truth is we underestimated it. They came in at EUR 465 million for the full year 2021. To give you a bit more color, about 70% of the increase related directly to raw materials and energy and about the remainder related to logistics and packaging. That's the context against which we mobilized. We mobilized the whole of our organization starting in the Q3 because we really were determined to accelerate our price increase actions in order to respond, in order to really face those challenges head on, because those cost pressures were very clear.
We're really proud of what the teams have accomplished, truly. We've overcome a significant amount of those costs. We've kept our assets running safely to keep utilizations very high, to ensure supply at the service of our customers. As a result, we protected our margins. Indeed, the significant progression in our pricing is evident to you on slide 16, and there a picture is better than a thousand words. What you can see here is that in Q3, we went from essentially standing still in the first half, we went up to 7% in Q3 and to an unparalleled, never done before, 12% in Q4. That's why we've improved our pricing power as the year progressed. We're really pleased with that.
On top of this, we continued to make good progress on our structural cost programs, which you can see in slide 17. In the Q4, we delivered EUR 40 million of additional savings. That brings the year's total to EUR 213 million for the year. We're giving you a breakdown of that into three key areas. Restructuring. These represent reductions in labor costs, and that contributed around EUR 75 million. Indirect costs, as we revisit, really approaching a zero-based philosophy to everything that we do. That delivered EUR 85 million last year. We've continued to focus on productivity efficiencies on our industrial sites, which came in with EUR 53 million. That really is associated with improving our manufacturing yields, which of course helps to support the volume growth.
Now, that brings the total of our structural savings so far to EUR 390 million across a two-year period. Well ahead of the targeted EUR 500 million euros reduction that we'd indicated by the end of 2024. Slide 18 shows that the positive demand development across many markets, combined with our successful price initiatives and our cost reductions, to help us deliver another quarter of strong EBITDA performance, up 24% on the Q4 of 2020 and up 27% for the full year. One-time impacts of net EUR 27 million in the Q4 were also reported in underlying EBITDA, and that includes EUR 61 million euros of one-time gains resulting from the Supreme Federal Court's retroactive decision on duty recoveries for many companies, including Solvay. We've recorded that gain in the chemical segment.
This gain was partially offset by a EUR 34 million loss, half of which related to bad debt in the energy business, clearly related to an unprecedented spike in energy costs, which we record in our corporate and business services segment. I'm gonna turn to cash generation on slide 19. The results of our efforts over the last two years to improve our cash generation are evident for all to see. For the 11th quarter in a row, we are generating positive free cash flow with EUR 151 million in Q4 last year and EUR 842 million for the full year 2021. How did we achieve this, strong performance? I'm gonna give you the main elements. I'll turn first to working capital. As you'd expect, strong top-line growth drove increases in inventories and receivables.
The good news is that we doubled down and even drove that discipline even further. Within that figure, you have structural improvements of around EUR 100 million of benefit and also the benefit of temporarily higher than usual payables because of high energy costs. We continue to manage very carefully our working capital with discipline. Total average working capital to sales in 2021 was 12.7% versus 14.7% in 2020. Mid to high teens is typically the industry standard, so we're really proud of this performance.
Turning to CapEx, we accelerated the investment in the Q4 to EUR 324 million, bringing the total for the year to EUR 736 million, in line with our guidance at the very beginning of last year of between EUR 700 million and EUR 750 million. Our ambitions to grow the business are high and our investment plans are concrete. We are now entering a growth cycle to prepare for the opportunities in the coming years, and Ilham already mentioned a few of these exciting projects. We also spent EUR 118 million on our restructuring programs, 26 million more than in 2020.
As you know, I consider this an investment because the payback is generally below two years. Finally, the deleveraging of our balance sheet has continued unabated, and the continued work on pensions and on debt reduction is paying off. Indeed, pension and financial charges were EUR 89 million lower than in 2020. Compared to 2019, they are EUR 190 million below 2019. As a consequence, our free cash flow conversion ratio is over 37% for the last twelve months. Again, it's higher than the ambition we set out of the structural free cash flow conversion ratio exceeding 30%. I do wanna make one additional comment, though.
I'd like to invite you to think of that 30% free cash flow conversion as a minimum average level that we expect to maintain going forward, even though investments in our growth projects may well cause that level to dip in a particular year. We also recommended a dividend increase of EUR 0.10, which, if approved, will bring the dividend to EUR 3.85 per share. Finally, a word on our net debt. Underlying net financial debt decreased again in 2021 by around EUR 250 million to EUR 3.95 billion, mainly due to the higher free cash flow generation, and that's despite an additional voluntary contribution towards pension obligations of EUR 236 million. Since the start of 2019, we've decreased our net debt by nearly EUR 1.6 billion.
We decreased our pensions by an additional EUR 1.1 billion. Today, the leverage ratio stands at 1.7 times, making it the lowest level we've had since 2015. Our credit strength and our strong ratings are really reinforced. With that, I'll hand you back to Ilham, who will discuss the full-year outlook for 2022.
Thank you, Karim. I'll now share some comments on our outlook for 2022. First, let me share our assumption. First, there will be a negative scope effect in 2022 of EUR 21 million due to the small divestments we made last year. Next, I want to acknowledge that the cost inflationary environment we continue to face is unprecedented in terms of volatility and financial impact. We also are aware of the geopolitical risk and continued uncertainty. In the light of these circumstances, we assume that things will neither improve nor get worse, and we remain focused on what is in our control. Our Q4 results demonstrate that we have the capability to take pricing actions to overcome the inflationary pressures, and going into 2022, this remains a top priority for our organization. We also continue to drive growth across our businesses.
Let me highlight some of these assumptions. In the materials segment, we expect growth to be driven by a few key areas, growth in auto, thanks to the shift toward electric vehicles and continued penetration of our high-performance polymers across all vehicle platforms. We shared with you this story just a few weeks ago during our webinar. LMC forecasts, as you may know, forecast a recovery in the auto market with an approximately 12% increase in global light vehicle production, 2022 versus 2021. The expectation is that the growth will be weighted toward the second half of 2022. This would provide a strong tailwind for our auto-facing polymer businesses, where we expect to continue to outperform the general market. Another growth driver is the continued recovery in civil aero that supports growth in Composites with single-aisle production rates increasing this year.
We estimate steady improvement in this business. We intend to share more details on this market in the coming months in a similar dedicated webinar to be held in May. In chemicals, Philippe just highlighted the expectations in the Soda Ash business. This is important because the growth in Soda Ash this year will help to offset the non-repeating effect of the super cycle that benefited us in 2021 related to Coatis and RusVinyl, both of which delivered around EUR 100 million more than their cycle average. In solutions, the segment is expected to grow modestly thanks to the demand for more sustainable solutions in a number of its markets, including agro, home and personal care, and others. We are seeing the success of the optimization strategy in this segment, and we see even more opportunities ahead.
Given this market view and taking into account our intention to invest more in capability in materials and digitalization and the fact that we expect pricing actions to accelerate this year, we estimate full year EBITDA to grow organically in the mid-single digit % range. On cash generation, we have clearly benefited from the improvements and the discipline in our processes over the past three years, and now we will be using some of this cash to fund our growth. I already mentioned a few of these investments earlier related to various high performance polymers capacity expansions. All together, this should bring our CapEx level in 2022 to around EUR 850 million-EUR 900 million, representing a 15%-20% increase versus 2021, of which half is inflation. Please be aware this doesn't indicate a sustained higher level of spend.
Think of it as an investment cycle where some years are higher than others as we prepare for future growth. The expected growth in the top line will likely result in higher working capital needs. This, together with our investment needs in 2022, brings us to a free cash flow estimate of at least EUR 650 million. Of course, this can fluctuate based on the activity levels as we will ensure we meet our customers' needs. As always, we will keep you informed of any changes during the course of the year. I'm sure this year will also have its share of challenges as we continue to emerge from this crisis and some of the secondary challenges it has created. Our team has demonstrated our ability to manage through these near-term headwinds.
Our solid and improving portfolio, coupled with our strong balance sheet and structural improvements, have enabled us to emerge leaner, stronger, and well-positioned to progress on our transformation journey and unlock value for our customers, shareholders, and our employees. With that, Karim and obviously Philippe as well, our guests today, and myself we're happy to take your questions.
Thank you, Ilham. We will now move to the Q&A, and I ask that you kindly limit yourself to one question per analyst so that we can address as many questions as possible today. Moderator, I'll hand the floor back to you.
Yes, thank you. Ladies and gentlemen, if you wish to ask a question, please press zero one on your telephone keypad. We have our first question from Daniel Cheng from [Redburn]. Please go ahead.
Hi there. Congratulations on the solid quarter. I've just got a couple of questions, if that's okay. First is on could you elaborate more on the execution of the pricing actions that have been taken beyond Soda Ash and maybe to sort of link that on to a follow-up. To get to your guidance then of EUR 2.45 billion of EBITDA, is that assuming pricing fully offset costs for the year?
Yeah. Hi, Dan. Well, definitely the pricing has been a new muscle we just started to train in the company. I mean, I'm not a newcomer anymore, but you know, we have our share of crises since I joined. When inflation hit us last year and second half looked very different from the first year, we had two types of businesses. One, you know, type or pool of businesses like Soda Ash, by the way, and Philippe can elaborate later on, where you know, we had contract pricing, you know, either based on you know, a number over a year with no formula or others with formula pricing linked to raw material like in silica with four months lag, right? Obviously we want to honor your yearly contract with your customers.
That's why we put a contract in place, but it was really unprecedented. Price became a real focus of our teams as from mid-2021 when raw materials and energy began to escalate, and we knew this is not something which is gonna be lasting for a quarter only. We have seen a broad-based progress on pricing. We shared best practices with our teams. We said it would take time. You remember I told you that in Q3 . You know, I'm really proud of our teams that in Q4 we saw this acceleration with 12% increases in the quarter. Really proud of many.
I will give probably the floor to Philippe to talk about what they have done in Soda Ash because it's the highlight when you know a team a management team and the sales you know teams are bold courageous and brave to go and reopen a contract during any given year and fight for protecting the margins and defend their value proposition. Obviously what was in a way almost even if it's painful we could actually reinitiate 2022. But before I do that obviously in Specialty Polymers for example it was another story because pricing was lagging in the three first quarters right? We really you know as you know in specialty polymer we have a unique value proposition. We went back to the market. We defended our value proposition.
The team, you know, succeeded to increase prices, and the acceleration allowed us to compensate the variable cost increase in Q4, right? While we had a margin, you know, squeeze in Q3 . It depends on each business. Novecare made good progress, but we expect more. As we enter in January, I can tell you that the pricing in Q4 is sticky. We are still looking at pool of pricing leakage, where we're not covering our variable costs. We are seeing some escalation on inflation more than what was even budgeted or seen in December. Listen, this is a muscle we are training. We're entering the year with renegotiated contract, including surcharges. Philippe, would you like to share your experience on reopening your contracts in Q4?
Yes, absolutely. Thank you, Ilham. Well, you know, in Soda, most of our contracts, let's say 90% of our contracts are fixed price negotiated on a yearly basis. The market last year was tight, so obviously we're able to pass price increases on the open volumes. Again, I mean, 90% of our volumes were locked. We soon realized that it was not sustainable, you know, to continue like that because of the unprecedented price increase on the energy markets. I mean, we're talking about, you know, on gas and coal four or five, even more times normal prices. It was absolutely key to squeeze a little bit the business already, you know, in 2021.
Of course, the market being tight, the customers wanting security of supply and visibility in the long term, and also, you know, investments that are required for energy transition and for new capacities in the future. We were able in a lot of cases, not to say in most of our cases, to get the support of our customers, and that's really something that was a nice surprise and a must, I must say, you know, to mitigate the risk. For 2022, obviously we renegotiated the prices in a situation where, again, the market is tight and costs are increasing.
Here, our target is not only to compensate the costs, but really to go beyond that and to get back, you know, to the profitability levels that we had pre-COVID in order to be able to continue to invest. Because we have big investments to be done, both in energy transition and in capacities.
Thank you. I think the price in Mesyl was underdeveloped historically and frankly, this inflation and environment, although again painful, it's really for me a nice opportunity to really engage with the business presidents, the sales organization, the technical staff, to really defend our value proposition. You know that Solvay had top-tier margins, so people know that we have great assets, we have great value proposition to offer to the world. Business by business, we are engaging with our customers and really proud of the 12% price increase. By the way, I think maybe some of you think that Coatis has done a really great job over the year, but even if you remove Coatis from the price increase, we are at double digits, you know, pricing increase.
It tells you that this is not coming only from the commodity side of the portfolio, but also from the specialties. Back to you.
Thank you very much.
Thank you.
We have another question from Lisa De Neve from Morgan Stanley. Please go ahead.
Hi. Good afternoon, Ilham and Karim. Thank you for taking my question. Maybe I slot in two, if I really may. Can you just share the free cash flow components that underpin your EUR 650 million guidance or minimum guidance for the year? Specifically, I'm looking at what are the sort of provisionals or the net working capital expectations that are baked into that number. Secondly, small question. Congratulations on your pricing in the quarter. On materials, you've delivered EUR 40 million pricing in 4Q in the backdrop of much higher PVDF pricing and sort of market tightness and higher raw materials. Can you share how much of that EUR 40 million was driven by PVDF pricing?
Can you start, Karim, with the 650?
I will start with the 650.
Yeah.
Maybe a couple of key comments I can help you with. Remember first of all, that we did indicate and promise to a minimum of 30% free cash flow conversion by 2024. We announced that in 2019. We've averaged 44% in the last two years. What I wanna highlight though, is I'd like to, as I said to you when I was giving my opening remarks, take that as a minimum average over time, and it really doesn't preclude that when we have a peak growth investment that it doesn't dip modestly. Don't be surprised if, for example, in 2022, it's a little below that 30%. It's important to note that, particularly, for example, it's very strategically coherent.
We said to you a few weeks ago that we're investing in batteries at a cost of EUR 300 million. Half of that's coming in this year. The other thing I wanna highlight is the EUR 736 million we invested this year. If you just take account of inflation, that will move it up towards EUR 800 million. Again, that tells you that in indicating EUR 850 million-EUR 900 million of CapEx, we're making space. We're allocating more to make space and drive that additional growth investment. That's the main one. I think so far as working capital is concerned, 12% is very, very low. Typically, I expect us to want to invest to serve our customers. Working capital investment to support our growth is something you can expect. It really is those two key factors that are the main drivers.
The other one, which is a little more modest, which is the incidence of our profit pools, will impact our effective tax rate by a couple of % here and there. That can easily add EUR 20 million-EUR 30 million of extra cash costs. That's totally dependent on exactly where which geographies those profits are made. Hope that helps, Lisa.
As you know by now, we'll not let go the free cash flow discipline in this company. We'll take it as a floor. Obviously, we want to reinvest. As Karim said, we have great investments and, you know, the markets welcomed our investments in Tavaux. We have few more in PSU, but also in electronics, in highly purified H₂O₂, and obviously in working capital as our customers need to. On your question on materials and price increase, I gave the example here on materials before Philippe kicked it in, Lisa is the highlight of Q4, right?
Really, the price increase acceleration allowed for the Q1 , frankly, since the past year or 18 months to compensate variable cost increase. This is across the board. Don't think it's only PVDF. Obviously, we have record sales in batteries, almost under allocation. The rebound in automotive is across the board, including for other high performing polymers, which go to under the hood application and go to lightweight. Despite the chip shortages, electronics is boosted by the 5G and smart devices, the mobile phones. All of this is actually booming with specialty polymers. We did a price over cost campaigns throughout the year and in Q4 with value capture initiatives. We looked at price leadership initiatives.
Where we have price leakages, we are giving much transparency on the pricing and the cost to all our, you know, product managers, salespeople, to really ensure that there is no, you know, that they understand the outliers. We are actually educating our salespeople, starting Specialty Polymers, but also expanding to other businesses on large deal negotiations. There is readiness process, which, you know, I've been through when I was a young salesperson, and I think it's good to go back to the basics. Multiple deals spanning the GBU portfolio across all large deal renegotiation. When you are in those, you know, inflationary environment, it's good to reopen your contract. We are looking at all our contracts, the payment terms, the pricing leakage, the outliers.
We have 40 or 60 deals ongoing now in negotiation, and obviously we are applying these new formats. Yeah, you can expect our prices increase to really go across the board. We shared it in the auto webinar that we were able to pass the cost increase to customers, also in auto as the demand is very strong and the supply is still limited. Back to you.
We have another question from Wim Hoste from KBC Securities. Go ahead.
Yes, good afternoon, and thanks for taking my question. I would like to ask your opinion on the management of the balance sheet. With leverage coming down, how are you looking at things like further reducing the pension deficits, lowering debt service costs? Are there any opportunities just in making your balance sheet more efficient?
That's a great question. I think this is a journey we've been on. We've really, as I mentioned, very big numbers have contributed to the deleveraging. What I want to highlight is everything we've done has created value. Just remember that the major reduction in our pension cash service costs and our financing costs is directly associated with that. We're talking of returns in excess of 10% after tax. It's fair to say we're coming towards the end of that particularly attractive deleveraging. The next chapter that's opening up is investing with real discipline. I think that's really key. At this stage, what I can say is that our credit strength is improving. Probably, I would speculate, I would suggest we're probably at the top end of our credit ratings, and we like that.
It gives us the ability to maneuver, to really invest and do the right thing. There is no more new major deleveraging opportunities. We have a bond that comes due of, I think, just over around EUR 380 million in September. We've got the cash to pay it. We don't have to raise new debt. It's a great position to be in. Maybe the only other thing I'll highlight is that with that cash, of course, we can look at CapEx. You know, we always look at the right opportunities for M&A, but again, it's not the lack of cash or firepower that gets in the way. It's the fact that we're very, very demanding on our expectations, on the value creation.
You know, we can look at things, and we're not gonna move unless we really find value, which is what we did early last year with the agro business.
Yeah.
that we bought. Ilham Kadri?
Yeah. No, I fully agree. Frankly, it's good to pause and enjoy the view. The pension, as you know, Wim, was the nail in the shoe of Solvay when I started in this company. I thank the teams, and specifically the finance team here, because the pension funding, there is a lot of negotiation and engagement with the trustees and different institutions across different countries which happened behind the curtain and hard work, and deleveraging and paying EUR 1.1 billion on pension and on net debt EUR 1.6 billion, unheard of, frankly, in two years and a half. Really enjoying to see a strong balance sheet. That's my belief. Any company should have a strong balance sheet.
Indeed, you know, we just have a luxury now to contemplate where to invest. We have. The good news is that since three years in the job, we built a really great organic growth platforms, right? Which you see. They are real, we can win, we can, you know, the opportunity is real. We are a winner and it's worth it economically, so we go for it. Obviously, we continue looking at strategic portfolio, but with a high level of discipline. The allocation of resources and the change in governance, which we did since March 2019, has paid dividends and this is not changing. Back to you.
We have another question from Chetan Udeshi from JP Morgan. Please go ahead.
Yeah. Hi, thanks. I just had few questions. First one was, I think within the provision line and also within the exceptional, I think there is a mention of EUR 123 million exceptional costs associated with results from legacy remediation and major litigations, which seems primarily related to remediation costs. I'm just curious to understand where this EUR 100 million remediation cost, like where. Like, which part of the business is this related to? Is this essentially going back to the PFAS remediation provisions that you guys are now starting to build up? Any color there would be useful.
Sorry, a bit technical here again. You know, if I look at the cash flow, there is a big bump in the dividend payments from associates and JVs from EUR 25 million in 2020 to almost EUR 130 million last year. Do you think this is sustainable going forward? Clearly, I think most of this might be coming from the EVC JV in Russia, but any color there would be useful. Last question, there's a big jump in revenue from non-core activities in Q4. I mean, it's more than double versus Q3 2021.
I think, you know, this is mainly related to your energy trading and sale business, but can you help us understand if this had any profit impact or EBITDA impact as well, given the, you know, significant increase in sales? Thank you.
Okay. Thank you, Chetan.
Great questions.
Do you want to take it?
No, sure. First and foremost, I think, let me start with the provision. There's nothing exceptional in the remediation line. Yes, it's a little higher than we've had historically, but there's nothing particular that jumps up in terms of there was a major outcome, a major cost that we flag. What I wanna highlight though is I'm gonna confirm what you said because your assumptions are absolutely spot on. The spike in dividends from non-controlled entities is really around RusVinyl. It's dividends, exceptional dividends. Again, we're benefiting from super cycle earnings. The great news is we're monetizing it, we're crystallizing, we're getting the cash, record dividends. That's the major part of it. On the non-core earnings, again, you're spot on. It really is around the equity accounting.
It's mainly revenue is the major element here, net of the one-time impacts that we disclose. Geoffroy, you wanna correct me? Go ahead, please. The revenue from non-core activities relate to the energy business predominantly. Okay. Sorry, I was looking at a different line. Thank you. That is absolutely the energy business and the one-time impact that we highlighted.
Mm-hmm.
Thanks, Chetan.
Does this answer your question, Chetan? He may be off. Yeah.
We have another question from Geoff Haire from UBS. Please go ahead.
Good afternoon. I was just wondering if we could talk a little bit about Specialty Polymers. Could you talk about the different trends that you may be seeing in volume terms for ICEs and EVs? Also talk a little bit about, do you see a big margin difference in the products that you're selling into ICEs and EVs, please?
Yeah, of course. I can take it up. Maybe, you know, for those who didn't actually listened or attended the webinar, we held a webinar dedicated to auto, and I think it's now, you know, available on our website. Our belief on ICE and move to hybrid and electric is that by 2030, half of the market will stay with ICE, internal combustion engine car, and the other half will move to hybrid and BEV. Obviously, you know, there is an ICE powertrain in the hybrid, so that's good for us. Along with the electric powertrain, we also shared with you that the opportunity is real for us. We've seen it.
It was stress tested during the COVID-19 because our frankly electric, you know, PVDF and other polymers to lighten the car has been just increasing, including, you know, in the midst of the crisis. Our numbers, we shared with you that we grew this business, you know, with a CAGR of 8% between 2016 and 2021, from EUR 500 million to EUR 800 million altogether. That this number will likely become EUR 1.5 billion by 2025 and can go above and, you know, and beyond EUR 2.5 billion by 2030. That's a great opportunity.
I mean, you see that investing in PVDF and upstream, you know, upstream monomers and feedstock is high barrier to entry. In fact, I was in Tavaux just few days ago to start and integrate, I mean, this new construction. Actually we are building five different plants, all vertically integrated. We also, what we told you in terms of the opportunities that we double our addressable market and value by market, which is great, for the company and the revenues. We are in suspension just to finish with the technology. Suspension as compared to emulsion, it's the supply of choice for high-end batteries. I mean, basically it gives better electric addition in NMC, for example, as compared to the emulsion technology.
All in all, we feel really good about that. The margins are as good as we have today. We will keep our margins, we will double the accessible market. We have the technology, the know-how, the customer access, the conversation, right? Our customers were really involved with us in making these investments happen in Europe, in localizing the value chain for batteries. At the end of the day, we're also agnostic to the cathode type. We are agnostic to the industry in a way because PVDF goes to other businesses. There is a de-risking here of the investment.
Obviously, you know that in Changshu, in China, we also doubled our capacity and we are now looking and discussing how to invest further, either in Asia or in the United States of America. Back to you.
Could you possibly comment on just what you're seeing currently in Q4 and what you expect to see in the first half of 2022 in terms of EVs and ICE demand?
Great question and you know, we've seen a very strong demand last year. Remember 2020 when we get out of it, obviously there was a lot of this talking during the crisis, et cetera, and you had to rebuild in 2021. In Q4, frankly, there was a lack of seasonality in Q4 with strong demand, especially in batteries, right? We've seen this very strongly. Order book entering into Q1 remains. I mean, our order book covers anywhere between eight weeks-10 weeks, right? For Specialty Polymers. Demand indicators continue to align strongly with the order book, and pricing remains the leading indicators right on there.
We shall see on the raw material, you know, and the inflation, how we're gonna engage into Q2 . You've seen LMC numbers, I shared them with you. It looks like, you know, they are very still comfortable, although it can change later, but confident that 2022 will deliver double-digit growth, probably heavily weighted towards the second half than the first half. For us, you know, the order books are still strong, and that's what we see today in our books. Back to you.
Is that order books in both ICE and EVs are still strong?
Yes. I mean, there is a strong demand in electric batteries, right, and demand for products for EV and hybrids, but definitely the ICE is still okay. Yeah.
Okay. Thank you.
Don't forget as well, just beyond what you see from the ICE build rate against electric hybrids is that we are also in lightweight, you know.
Mm-hmm.
We enter the existing models and the existing technology. Whenever we can replace metal and we can lighten the vehicle, which goes, as you know, into cutting the emissions and allowing the car manufacturers to become more sustainable. You heard it from, you know, again, celebrate that Philippe is with us, that EV, it's emerging, is small, is new, but will be also benefiting the mining and the Soda Ash businesses. Back to you.
Okay. Thank you.
Thank you.
We have another question from Mubasher Chaudhry from Citi. Please go ahead.
Hi. Thank you for taking my question. Just the one please. You've had relatively good performance and cash generation as well, and you talked about deleveraging and having a good balance sheet and starting to focus on organic investment. Is it fair to say from a capital allocation perspective that the focus is very much on organic delivery and focusing on the business as it currently stands, therefore M&A is off the table? And if not, if there's any preference for size or in market exposure that you'd be most excited by from an M&A perspective. Thank you.
Yeah. Thank you, Mubasher. Well, listen, I think you're right. Since I joined the company, frankly, my first objective was to deleverage the balance sheet, to make the cash generation, not a Q4 story, but a quarterly story with high discipline. You remember we've changed our incentives and frankly, this organization had just responded, you know, better than good, yeah. We really trained the muscle. Very happy with the generation of the cash across all the businesses. I think, again, Philippe is here and so that as you know, it has been and is a resilient cash generator, but other businesses, Specialty Polymers and hydrogen peroxide, et cetera, they're equally, you know, generating quality, free cash flow and the conversion has been really good.
Now, in terms of investments, since I joined the company, I was really looking at what are those key big bets we have in terms of organic growth. We do have quite a substantial great projects, and you've seen them. I mean, batteries is one. We're investing in thermoplastic composites. We just finished our investments in Greenville in the United States of America. Green hydrogen is still small, but we are putting a semi-commercial plant for Aquivion membrane for green hydrogen. We announced earlier this week the PSU, the Udel story for healthcare, high-margin businesses, and then ultra-purified H₂O₂ peroxide, which goes to semiconductors. The world is short and thirsty for getting more semiconductors, and our customers are asking us to invest very close to them.
After our joint venture and alliance in Taiwan, we are looking at investments here in Europe. We don't have yet the final choice of the manufacturing plant, but we will inform you. On the inorganic side, first of all, there is no sacred cow. We look at it from the strategic planning point of view, we are disciplined, and if there is a strategic fit and we believe we can be the best owner, the next question for me will be how much it will cost. Is it creating value? I know our history has been debated a bit on past acquisitions, so we will look at it and we do it right, including the synergies.
What are they? What are the expected returns? No emotion. It's very clinical, based on facts, and we will be extremely disciplined on any inorganic M&A.
Sorry. Just to come back to you on that. Is there any limitation on size and anything? Would you be keen to go for bolt-on size or that doesn't matter regardless if it matches the investment criteria and is attractive, you're open to bigger ticket M&A as well?
No. I don't want here to you know to change the risk profile of the company, right? I'm very careful with the big acquisition. Remember, I mean, we exited a cycle of 50 M&As after the acquisition of Rhodia and Cytec. We had actually to merge those, you know, integrate them, build the synergies, which happened very recently. We contemplated, and we still do small M&As to buy and build in agro. You remember we did a small one last year. That's good. Big is not necessarily beautiful or profitable. I've seen many bigs in my career. I'm very prudent and I will continue to look obviously at all the options on the table, but with discipline in returns.
Back to you.
Understood. Thank you.
We are going to take a last question. Andreas Heine from Stifel. You have the floor.
Yes. Thanks for having this opportunity to ask the last question. It's on soda ash, actually. I would like to come back to the comments you made on what soda ash can deliver this year in the context of the over-earning of Coatis and RusVinyl. And you said that the last two were over-earning by EUR 100 million last year, might not do this year. Is that right that you are so optimistic that soda ash might increase earnings by EUR 200 million this year on the tight market and the price increases you have achieved at the beginning of the year? The first question. The second related to this is soda ash variable costs are highly dependent on the energy costs.
My understanding is in looking at your report, you have quite high hedges in energy. How is it for 2022 in the current market? You have now the annual price, and you know where energy prices are currently on the spot market. How you handle hedging your energy position or will it be a more open position this year? Thanks.
Yeah, yeah. I will give the energy question. I will leave it to Philippe as he's with us. But definitely, on the EUR 100 million, you know, we're not saying. I mean, there is a super cycle, you understood it from Coatis and Rusvinyl, which we evaluated around EUR 100 million. This is baked in our, you know, guidance of, you know, mid-single-digit % for the EBITDA for 2022. We don't give guidance by GBU and by business, right? But obviously, we'll give you more color as I expose some of my GBU presidents over the year to give you the quality of the business. I think what Philippe is saying is that, after 2020, where we elected to let go some low profitable volumes in the market, we did it really intentionally, right?
Frankly, it worked very well for us in 2021. We actually, you know, really, we were more resilient and more profitable than our competitors, right? Because we have discipline, we protect our margins, and, you know, we renegotiated our prices. I thank again Philippe and his team to be bold and courageous to reopen historically some of the contracts, and not only to see the impact in Q4, but definitely in 2022, including having energy surcharge. Philippe, can you build on that?
Yes, absolutely. Thanks a lot, Andreas, for the question. Indeed, I mean, we are extremely exposed to energy markets, as you know, it's the biggest part of our variable costs. Well, the answer is very simple. It's a combination, you know, of a hedge that we've taken, and also, you know, under the current circumstances, some new contractual clauses that allow us, in some cases, either to pass on, you know, those extra energy costs, in particular, if they continue, you know, to go up, and we fear this might happen given the context. Also some reopeners that would allow us to pass some price increases. This is exactly what we're doing.
What I would like to mention on top of that is that it's highlighting the fact that doing the energy transition is key. Because moving, you know, from coal or gas to refuse derived fuel, biomass, and so on, with local sourcing that we can secure on the long term, help us, you know, to get out of this huge volatility that we see, you know, increasing month after month on the fossil fuel energy markets.
Yeah.
Thank you.
Thank you. And you know, to clarify, you know, it's 100, it's not 200, so I don't want you to walk away with that number. Yeah, just to be clear. Well, listen, I think it's the last question, and I would like really to thank Philippe. He's the first one, you know, joining us in an earnings call, and you will see us, you know, having guests and from different businesses as we continue building the equity stories of our strong and robust portfolio. Thank you. Thank you very much.
Thank you everyone. This concludes our call today, and as always, the IR team is available for any follow-up questions that you may have. Thank you so much and have a good day.